Description EZ Peptides AOD-9604 5MG Research-Grade Compound AOD-9604 5MG is a research-grade compound supplied in a sterile vial, intended for use in controlled laboratory settings
Comparing These Four Peptides | Compound | Primary Target | Main Effect | |---|---|---| | Sermorelin | GHRH Receptor | Stimulates endogenous GH release | | CJC-1295 | GHRH Receptor | Sustained GH stimulation | | Ipamorelin | Ghrelin Receptor (GHS-R1a) | Triggers GH secretion | | IGF-1 LR3 | IGF-1 Receptor | Direct tissue-level IGF signaling | For a deeper dive into the specific compounds available, see our Peptide Therapy Education page, which catalogs 23 active peptide compounds with full mechanism-of-action references
The addition of glucagon receptor agonism introduces a third axis: increased energy expenditure, enhanced hepatic fat oxidation, and PCSK9-mediated reduction in LDL cholesterol
It is being studied for obesity and related metabolic conditions, including type 2 diabetes
The Takeaway If youre experiencing hair loss while on a GLP-1 medication or when postpartum or perimenopause, dont ignore ityour hair is often a good metric of your overall health
In one study, up to 80% of participants experienced excessive glucose spikes after consuming cornflakes and milk [6] a relatively common breakfast among many adults and children
